Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis
Background Although dual antiplatelet therapy (DAPT) improves the outcomes of patients
undergoing percutaneous coronary intervention (PCI), sex-specific differences in efficacy …
undergoing percutaneous coronary intervention (PCI), sex-specific differences in efficacy …
LASSO-derived model for the prediction of bleeding in aspirin users
C Liang, L Wanling, W Maofeng - Scientific Reports, 2024 - nature.com
Aspirin is widely used for both primary and secondary prevention of panvascular diseases,
such as stroke and coronary heart disease (CHD). The optimal balance between reducing …
such as stroke and coronary heart disease (CHD). The optimal balance between reducing …
Clopidogrel Monotherapy for Double-Risk Acute Coronary Syndrome
M Valgimigli, A Landi - JAMA cardiology, 2024 - jamanetwork.com
In this issue of JAMA Cardiology, Li et al1 report the results of the double-blind, placebo-
controlled Optimal Antiplatelet Therapy for High Bleeding and Ischemic Risk Patients (OPT …
controlled Optimal Antiplatelet Therapy for High Bleeding and Ischemic Risk Patients (OPT …
Effects of dual antiplatelet therapy (DAPT) compared to single antiplatelet therapy (SAPT) in patients with traumatic brain injury
R Sashida, E Suehiro, T Tanaka, N Shiomi… - Clinical neurology and …, 2024 - Elsevier
Japan is one of the world's most aging societies and the number of elderly patients taking
antithrombotic drugs is increasing. In recent years, dual antiplatelet therapy (DAPT), in which …
antithrombotic drugs is increasing. In recent years, dual antiplatelet therapy (DAPT), in which …
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial
Aims Screening logs have the potential to appraise the actual prevalence and distribution of
predefined patient subsets, avoiding selection biases, which are inevitably and potentially …
predefined patient subsets, avoiding selection biases, which are inevitably and potentially …
Negative selection bias for women inclusion in a clinical trial
Introduction Despite the growing awareness towards the importance of adequate
representation of women in clinical trials among patients treated with percutaneous coronary …
representation of women in clinical trials among patients treated with percutaneous coronary …
Acute coronary syndrome: Definition, pathophysiology, diagnosis, and management
EAC Estrada, ERM Sequeda, JEB Barros… - World Journal of …, 2024 - wjarr.com
Acute coronary syndrome (ACS) represents the most severe form of presentation of ischemic
heart disease and imposes a significant burden on morbidity and mortality worldwide …
heart disease and imposes a significant burden on morbidity and mortality worldwide …
[PDF][PDF] Heightened Thrombogenicity in Black Females: A Major Unrecognized Deleterious Risk Factor
MD Damian Sidorski, P Gurbel, PA Gurbel - drive.google.com
Background: Race and gender based disparities exist in cardiovascular risk factors risk
factors, and in the prevalence, and clinical outcomes of cardiovascular disease (CVD). The …
factors, and in the prevalence, and clinical outcomes of cardiovascular disease (CVD). The …